Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes...
-
Upload
samantha-montgomery -
Category
Documents
-
view
218 -
download
2
Transcript of Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes...
![Page 1: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/1.jpg)
Diabetes: Pathophysiology -- Type 2 Diabetes
Lekshmi T. Nair, MDDivision of Endocrinology, Diabetes and
MetabolismEmail: [email protected]
![Page 2: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/2.jpg)
Learning Objectives
Discuss
• the pathophysiology of type 2 diabetes
Describe
• indications and procedures for screening and diagnosis of type 2 diabetes
Identify
• the typical clinical characteristics of type 2 diabetes and how to distinguish from Type 1 diabetes.
Describe
• causes of insulin resistance.
Describe
• other specific types of diabetes including LADA (Latent Autoimmune Diabetes of Adulthood)
Recognize
• the clinical characteristics of Hyperosmolar Hyperglycemic State (HHS)/Hyperosmolar Hyperglycemic Non-Ketotic State (HHNK)
![Page 3: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/3.jpg)
Content: Background -- Epidemiology of Diabetes(US data released 1/26/2011)
Incidence: 1.9 million adults diagnosed with DM in 2010
Prevalence: Affects 25.8 million children and adults
Prevalence by race varies
DM carries significant morbidity, mortality and health care costs
![Page 4: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/4.jpg)
Content: Classification of Diabetes - 1
![Page 5: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/5.jpg)
Content: Classification of Diabetes - 2
Type 1 diabetes mellitus (T1DM) Type 2 diabetes mellitus (T2DM) Other types of diabetes mellitus: DM is a secondary
process or consequence of primary pathology Gestational diabetes mellitus (GDM) Latent Autoimmune Diabetes of Adulthood (LADA) Monogenic forms of Diabetes Mellitus (MODY)
![Page 6: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/6.jpg)
Content: Clinical Characteristics of T1DM vs T2DM
TYPE 1 TYPE 2
Other terms “Juvenile onset““Brittle DM”“Latent onset“
“Adult onset”“Maturity onset”
Typical Age of Diagnosis
< 30 > 40
Onset Abrupt Gradual
Ketosis Common Rare
Body habitus Usually thin 80% obese
Twin concordance 40-50% Almost 100%
Insulin needed Always Variable
![Page 7: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/7.jpg)
Content: Diagnosis of diabetes mellitus
Diabetes Mellitus Impaired
Fasting glucose ≥ 126mg/dL 100-125 mg/dL
2 hr glucose ≥ 200mg/dL
140-199 mg/dL
A1c ≥ 6.5% 5.7-6.4%
Random glucose ≥ 200mg/dL with symptoms
Source: American Diabetes Association, 2011.
![Page 8: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/8.jpg)
Content: Screening for diabetes mellitus
• ADA recommendations:• All individuals > 45 years every 3 years• Earlier if overweight (BMI >25) and with additional risk
factor that is correlated with increased incidence of diabetes.
Source: American Diabetes Association, 2011.
![Page 9: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/9.jpg)
Content: Pathophysiology of diabetes mellitus
Normal glucose homeostasis relies on a delicate balance between glucose production and utilization.
Hepatic glucose production
Peripheral glucose uptake/utilization
InsulinGlucagon
Neural InputOther hormone
![Page 10: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/10.jpg)
Content: Pathophysiology of diabetes mellitus
Hepatic glucose production
Peripheral glucose uptake/utilization
InsulinGlucagonNeural InputOther hormone
Fasting glucose
Postprandial glucose
Multiple Defects in the Setting of Type 2 Diabetes
![Page 11: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/11.jpg)
Content: Pathophysiology of diabetes mellitus
Reduced insulin secretion
Increased/inappropriate hepatic glucose productionPeripheral
insulin resistance Abnormal fat
metabolismDiminished incretin
secretion Diminished amylin secretion
Progressive Hyperglycemia
![Page 12: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/12.jpg)
Adapted from Holman RR. Diabetes Res Clin Pract. 1998;40(suppl):S21-S25. UKPDS Group. Diabetes. 1995;44:1249-1258. Reproduced with permission from Elsevier.
0
20
40
60
80
100
10 9 8 7 6 5 4 3 2 1 0 1 2 3 4 5 6
HOMA = homeostasis model assessment
Content: Pathophysiology of diabetes mellitusDeclining β-cell Function in T2DM
β-c
ell
Fu
nct
ion
(% o
f n
orm
al b
y H
OM
A)
Years
Time of Diagnosis
Pancreatic function = 50% of normal at time
of diagnosis
?Decreasing β-cell function possibly for many years prior to diagnosis
![Page 13: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/13.jpg)
Content: Type 2 Diabetes – Insulin resistance + Impaired Insulin secretion
Genetics. Adiposity.Insulin
signaling defects.
Reduced glucose
utilization.
![Page 14: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/14.jpg)
Kahn SE. J Clin Endocrinol Metab. 2001;86:4047-4058.Ludwig DS. JAMA. 2002;287:2414-2423.
Content: Factors That Contribute to Progressive Nature of Type 2 Diabetes
InsulinResistance
Glucose Toxicity(hyperglycemia)
-CellDysfunction
“Lipotoxicity”(elevated FFA, TG)
FFA = free fatty acids; TG = triglycerides.
![Page 15: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/15.jpg)
Adapted from Ramlo-Halsted BA, et al. Prim Care. 1999;26:771-789. Reproduced with permission from Elsevier and the Council for the Advancement of Diabetes Research and Education (CADRE).
Content: The Natural History of T2DMDecreasing Insulin Secretion in the Context of Insulin Resistance Leads to
Increases in Blood Glucose and Diabetes Complications
Impairedglucose tolerance
Undiagnoseddiabetes Known diabetes
Macrovascular complicationsMicrovascular complications
Insulin resistance
Postprandial glucose
Fasting glucose
β-cell functionInsulin secretion
Time
![Page 16: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/16.jpg)
Content: Complications in Type 2 Diabetes Mellitus
Acute complications HHNK
Chronic Complications Macrovascular Microvascular
![Page 17: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/17.jpg)
Content: Hyperosmolar Hyperglycemic Non-Ketotic State (HHNK)
Important features:
Little or no ketoacid accumulation.
Typically very elevated plasma glucose.
The plasma osmolality is elevated.
Dehydration is present.
Neurologic abnormalities are frequently present.
![Page 18: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/18.jpg)
Content: Common precipitating factors in HHNK Pneumonia Urinary tract infection Alcohol and drug abuse Silent myocardial infarction Stroke Pancreatitis Trauma Drugs (e.g. steroids and higher dose thiazide diuretics) Hot weather and insufficient water intake in elderly
patients
![Page 19: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/19.jpg)
Glycosuria
Dehydration HYPEROSMOLARITY
Content: What happens in HHNK?
![Page 20: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/20.jpg)
Content: HHNK treatment
Stabilize hemodynamically Electrolyte correction. Correct glucose gradually. (IV fluids + IV insulin)
![Page 21: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/21.jpg)
Summary
Pathophysiology of T2DM involves both insulin resistance and secretion defects.
Age and risk factors help determine who should be screened for T2DM.
Screening for T2DM may involve a glucose tolerance test and/or hemoglobin A1C and ADA described goals.
T1DM and T2DM typically vary in clinical characteristics but it is important to consider exceptions and other types of diabetes.
HHNK results from progressive hyperglycemia and dehydration leading to hyperosmolar state.
![Page 22: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/22.jpg)
Pathophysiology of Type2 Diabetes Quiz
![Page 24: Diabetes: Pathophysiology -- Type 2 Diabetes Lekshmi T. Nair, MD Division of Endocrinology, Diabetes and Metabolism Email: lekshmi.nair@osumc.edu.](https://reader036.fdocuments.us/reader036/viewer/2022062423/56649e9e5503460f94b9ff51/html5/thumbnails/24.jpg)
Survey
We would appreciate your feedback on this module. Click on the button below to complete a brief survey. Your responses and comments will be shared with the module’s author, the LSI EdTech team, and LSI curriculum leaders. We will use your feedback to improve future versions of the module.
The survey is both optional and anonymous and should take less than 5 minutes to complete.
Survey